Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i> Mutant Pancreatic CancerCraig M. Goodwin, Channing J. Der, Andrew M. Waters et al.|Cancer Research|2022Cited by 160
Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant CancersIrem Ozkan‐Dagliyan, Channing J. Der, Laura E. Herring et al.|Cell Reports|2020Cited by 108
Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer.Mareen Lüthen, Sehrish Javaid, Jennifer E. Klomp et al.|UNC Libraries|2024Cited by 12
Silencing of oncogenic KRAS by mutant-selective small interfering RNABjoern Papke, Chad V. Pecot|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 2
Abstract LB-287: Combination therapies with CDK4/6 inhibitors to treat <i>KRAS-</i>mutant pancreatic cancerCraig M. Goodwin, Channing J. Der, Sehrish Javaid et al.|Cancer Research|2019Cited by 1